FDA To Fast-Track Reviews Of Three Psychedelic Mental Health Drugs
2h
Developing
1
The Food and Drug Administration said Saturday it will fast-track reviews of three psychedelic drugs for mental-health treatment, responding to a White House order to speed development and expand access.